Safety and Efficacy Study of Asfotase Alfa in Adolescents and Adults With Hypophosphatasia (HPP)
Clinical trial NCT01163149 · COMPLETED
Trial details
- NCT number
- NCT01163149
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2016-06-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.